English
简体中文
Total: £ 56.28
Published Date: 2022-08-30 | Pages: 88 | Tables: 124 | Medical Care
Market Analysis and Insights: Global Cancer Supportive Care Drugs Market
Cancer Supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects.
The global Cancer Supportive Care Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Granulocyte-Colony Stimulating Factors (G-CSFS) accounting for % of the Cancer Supportive Care Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Breast Cancer segment is altered to an % CAGR throughout this forecast period.
China Cancer Supportive Care Drugs market size is valued at US$ million in 2021, while the North America and Europe Cancer Supportive Care Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cancer Supportive Care Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Supportive Care Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Supportive Care Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Supportive Care Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Supportive Care Drugs market.
Global Cancer Supportive Care Drugs Scope and Market Size
Cancer Supportive Care Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Supportive Care Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Granulocyte-Colony Stimulating Factors (G-CSFS)
Erythropoietin-Stimulating Agents (ESAS)
Antiemetics
Bisphosphonates
Opioids
Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
Others
Segment by Application
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Johnson & Johnson
Novartis
Baxter International
Fagron Group
Teva Pharmaceuticals Industries
F.Hoffmann La-Roche Ltd
Apr Applied Pharma Science Research
Acacia Pharma
Kyowa Hakko Kirin
Helsinn Healthcare
Heron Pharma
Merck & Co. Inc
Sanofi
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Granulocyte-Colony Stimulating Factors (G-CSFS)
1.2.3 Erythropoietin-Stimulating Agents (ESAS)
1.2.4 Antiemetics
1.2.5 Bisphosphonates
1.2.6 Opioids
1.2.7 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Cancer Supportive Care Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Melanoma
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Supportive Care Drugs Market Perspective (2017-2028)
2.2 Cancer Supportive Care Drugs Growth Trends by Region
2.2.1 Cancer Supportive Care Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Supportive Care Drugs Historic Market Size by Region (2017-2022)
2.2.3 Cancer Supportive Care Drugs Forecasted Market Size by Region (2023-2028)
2.3 Cancer Supportive Care Drugs Market Dynamics
2.3.1 Cancer Supportive Care Drugs Industry Trends
2.3.2 Cancer Supportive Care Drugs Market Drivers
2.3.3 Cancer Supportive Care Drugs Market Challenges
2.3.4 Cancer Supportive Care Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Supportive Care Drugs Players by Revenue
3.1.1 Global Top Cancer Supportive Care Drugs Players by Revenue (2017-2022)
3.1.2 Global Cancer Supportive Care Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Supportive Care Drugs Revenue
3.4 Global Cancer Supportive Care Drugs Market Concentration Ratio
3.4.1 Global Cancer Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Supportive Care Drugs Revenue in 2021
3.5 Cancer Supportive Care Drugs Key Players Head office and Area Served
3.6 Key Players Cancer Supportive Care Drugs Product Solution and Service
3.7 Date of Enter into Cancer Supportive Care Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Supportive Care Drugs Breakdown Data by Type
4.1 Global Cancer Supportive Care Drugs Historic Market Size by Type (2017-2022)
4.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2023-2028)
5 Cancer Supportive Care Drugs Breakdown Data by Application
5.1 Global Cancer Supportive Care Drugs Historic Market Size by Application (2017-2022)
5.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Supportive Care Drugs Market Size (2017-2028)
6.2 North America Cancer Supportive Care Drugs Market Size by Country (2017-2022)
6.3 North America Cancer Supportive Care Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Supportive Care Drugs Market Size (2017-2028)
7.2 Europe Cancer Supportive Care Drugs Market Size by Country (2017-2022)
7.3 Europe Cancer Supportive Care Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Supportive Care Drugs Market Size (2017-2028)
8.2 Asia-Pacific Cancer Supportive Care Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Supportive Care Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Supportive Care Drugs Market Size (2017-2028)
9.2 Latin America Cancer Supportive Care Drugs Market Size by Country (2017-2022)
9.3 Latin America Cancer Supportive Care Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Supportive Care Drugs Market Size (2017-2028)
10.2 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Supportive Care Drugs Introduction
11.1.4 Amgen Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Cancer Supportive Care Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Cancer Supportive Care Drugs Introduction
11.3.4 Novartis Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Detail
11.4.2 Baxter International Business Overview
11.4.3 Baxter International Cancer Supportive Care Drugs Introduction
11.4.4 Baxter International Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.4.5 Baxter International Recent Development
11.5 Fagron Group
11.5.1 Fagron Group Company Detail
11.5.2 Fagron Group Business Overview
11.5.3 Fagron Group Cancer Supportive Care Drugs Introduction
11.5.4 Fagron Group Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.5.5 Fagron Group Recent Development
11.6 Teva Pharmaceuticals Industries
11.6.1 Teva Pharmaceuticals Industries Company Detail
11.6.2 Teva Pharmaceuticals Industries Business Overview
11.6.3 Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Introduction
11.6.4 Teva Pharmaceuticals Industries Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.6.5 Teva Pharmaceuticals Industries Recent Development
11.7 F.Hoffmann La-Roche Ltd
11.7.1 F.Hoffmann La-Roche Ltd Company Detail
11.7.2 F.Hoffmann La-Roche Ltd Business Overview
11.7.3 F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Introduction
11.7.4 F.Hoffmann La-Roche Ltd Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.7.5 F.Hoffmann La-Roche Ltd Recent Development
11.8 Apr Applied Pharma Science Research
11.8.1 Apr Applied Pharma Science Research Company Detail
11.8.2 Apr Applied Pharma Science Research Business Overview
11.8.3 Apr Applied Pharma Science Research Cancer Supportive Care Drugs Introduction
11.8.4 Apr Applied Pharma Science Research Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.8.5 Apr Applied Pharma Science Research Recent Development
11.9 Acacia Pharma
11.9.1 Acacia Pharma Company Detail
11.9.2 Acacia Pharma Business Overview
11.9.3 Acacia Pharma Cancer Supportive Care Drugs Introduction
11.9.4 Acacia Pharma Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.9.5 Acacia Pharma Recent Development
11.10 Kyowa Hakko Kirin
11.10.1 Kyowa Hakko Kirin Company Detail
11.10.2 Kyowa Hakko Kirin Business Overview
11.10.3 Kyowa Hakko Kirin Cancer Supportive Care Drugs Introduction
11.10.4 Kyowa Hakko Kirin Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.10.5 Kyowa Hakko Kirin Recent Development
11.11 Helsinn Healthcare
11.11.1 Helsinn Healthcare Company Detail
11.11.2 Helsinn Healthcare Business Overview
11.11.3 Helsinn Healthcare Cancer Supportive Care Drugs Introduction
11.11.4 Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.11.5 Helsinn Healthcare Recent Development
11.12 Heron Pharma
11.12.1 Heron Pharma Company Detail
11.12.2 Heron Pharma Business Overview
11.12.3 Heron Pharma Cancer Supportive Care Drugs Introduction
11.12.4 Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.12.5 Heron Pharma Recent Development
11.13 Merck & Co. Inc
11.13.1 Merck & Co. Inc Company Detail
11.13.2 Merck & Co. Inc Business Overview
11.13.3 Merck & Co. Inc Cancer Supportive Care Drugs Introduction
11.13.4 Merck & Co. Inc Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.13.5 Merck & Co. Inc Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Cancer Supportive Care Drugs Introduction
11.14.4 Sanofi Revenue in Cancer Supportive Care Drugs Business (2017-2022)
11.14.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Granulocyte-Colony Stimulating Factors (G-CSFS)
Table 3. Key Players of Erythropoietin-Stimulating Agents (ESAS)
Table 4. Key Players of Antiemetics
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Opioids
Table 7. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
Table 8. Key Players of Others
Table 9. Global Cancer Supportive Care Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Cancer Supportive Care Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Cancer Supportive Care Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Cancer Supportive Care Drugs Market Share by Region (2017-2022)
Table 13. Global Cancer Supportive Care Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Cancer Supportive Care Drugs Market Share by Region (2023-2028)
Table 15. Cancer Supportive Care Drugs Market Trends
Table 16. Cancer Supportive Care Drugs Market Drivers
Table 17. Cancer Supportive Care Drugs Market Challenges
Table 18. Cancer Supportive Care Drugs Market Restraints
Table 19. Global Cancer Supportive Care Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Cancer Supportive Care Drugs Market Share by Players (2017-2022)
Table 21. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Drugs as of 2021)
Table 22. Ranking of Global Top Cancer Supportive Care Drugs Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Cancer Supportive Care Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cancer Supportive Care Drugs Product Solution and Service
Table 26. Date of Enter into Cancer Supportive Care Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Supportive Care Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2017-2022)
Table 30. Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2023-2028)
Table 32. Global Cancer Supportive Care Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2017-2022)
Table 34. Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Cancer Supportive Care Drugs Revenue Market Share by Application (2023-2028)
Table 36. North America Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Cancer Supportive Care Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Cancer Supportive Care Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Cancer Supportive Care Drugs Product
Table 49. Amgen Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Cancer Supportive Care Drugs Product
Table 54. Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Cancer Supportive Care Drugs Product
Table 59. Novartis Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Baxter International Company Detail
Table 62. Baxter International Business Overview
Table 63. Baxter International Cancer Supportive Care Drugs Product
Table 64. Baxter International Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 65. Baxter International Recent Development
Table 66. Fagron Group Company Detail
Table 67. Fagron Group Business Overview
Table 68. Fagron Group Cancer Supportive Care Drugs Product
Table 69. Fagron Group Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 70. Fagron Group Recent Development
Table 71. Teva Pharmaceuticals Industries Company Detail
Table 72. Teva Pharmaceuticals Industries Business Overview
Table 73. Teva Pharmaceuticals Industries Cancer Supportive Care Drugs Product
Table 74. Teva Pharmaceuticals Industries Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 75. Teva Pharmaceuticals Industries Recent Development
Table 76. F.Hoffmann La-Roche Ltd Company Detail
Table 77. F.Hoffmann La-Roche Ltd Business Overview
Table 78. F.Hoffmann La-Roche Ltd Cancer Supportive Care Drugs Product
Table 79. F.Hoffmann La-Roche Ltd Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 80. F.Hoffmann La-Roche Ltd Recent Development
Table 81. Apr Applied Pharma Science Research Company Detail
Table 82. Apr Applied Pharma Science Research Business Overview
Table 83. Apr Applied Pharma Science Research Cancer Supportive Care Drugs Product
Table 84. Apr Applied Pharma Science Research Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 85. Apr Applied Pharma Science Research Recent Development
Table 86. Acacia Pharma Company Detail
Table 87. Acacia Pharma Business Overview
Table 88. Acacia Pharma Cancer Supportive Care Drugs Product
Table 89. Acacia Pharma Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 90. Acacia Pharma Recent Development
Table 91. Kyowa Hakko Kirin Company Detail
Table 92. Kyowa Hakko Kirin Business Overview
Table 93. Kyowa Hakko Kirin Cancer Supportive Care Drugs Product
Table 94. Kyowa Hakko Kirin Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 95. Kyowa Hakko Kirin Recent Development
Table 96. Helsinn Healthcare Company Detail
Table 97. Helsinn Healthcare Business Overview
Table 98. Helsinn Healthcare Cancer Supportive Care DrugsProduct
Table 99. Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 100. Helsinn Healthcare Recent Development
Table 101. Heron Pharma Company Detail
Table 102. Heron Pharma Business Overview
Table 103. Heron Pharma Cancer Supportive Care DrugsProduct
Table 104. Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 105. Heron Pharma Recent Development
Table 106. Merck & Co. Inc Company Detail
Table 107. Merck & Co. Inc Business Overview
Table 108. Merck & Co. Inc Cancer Supportive Care DrugsProduct
Table 109. Merck & Co. Inc Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 110. Merck & Co. Inc Recent Development
Table 111. Sanofi Company Detail
Table 112. Sanofi Business Overview
Table 113. Sanofi Cancer Supportive Care DrugsProduct
Table 114. Sanofi Revenue in Cancer Supportive Care Drugs Business (2017-2022) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Supportive Care Drugs Market Share by Type: 2021 VS 2028
Figure 2. Granulocyte-Colony Stimulating Factors (G-CSFS) Features
Figure 3. Erythropoietin-Stimulating Agents (ESAS) Features
Figure 4. Antiemetics Features
Figure 5. Bisphosphonates Features
Figure 6. Opioids Features
Figure 7. Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) Features
Figure 8. Others Features
Figure 9. Global Cancer Supportive Care Drugs Market Share by Application in 2021 & 2028
Figure 10. Breast Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Melanoma Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Cancer Supportive Care Drugs Report Years Considered
Figure 16. Global Cancer Supportive Care Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Cancer Supportive Care Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Cancer Supportive Care Drugs Market Share by Region: 2021 VS 2028
Figure 19. Global Cancer Supportive Care Drugs Market Share by Players in 2021
Figure 20. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Supportive Care Drugs as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2021
Figure 22. North America Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America Cancer Supportive Care Drugs Market Share by Country (2017-2028)
Figure 24. United States Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Cancer Supportive Care Drugs Market Share by Country (2017-2028)
Figure 28. Germany Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Cancer Supportive Care Drugs Market Share by Region (2017-2028)
Figure 36. China Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Cancer Supportive Care Drugs Market Share by Country (2017-2028)
Figure 44. Mexico Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Cancer Supportive Care Drugs Market Share by Country (2017-2028)
Figure 48. Turkey Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia Cancer Supportive Care Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 51. Johnson & Johnson Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 52. Novartis Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 53. Baxter International Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 54. Fagron Group Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 55. Teva Pharmaceuticals Industries Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 56. F.Hoffmann La-Roche Ltd Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 57. Apr Applied Pharma Science Research Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 58. Acacia Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 59. Kyowa Hakko Kirin Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 60. Helsinn Healthcare Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 61. Heron Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 62. Merck & Co. Inc Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 63. Sanofi Revenue Growth Rate in Cancer Supportive Care Drugs Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
